Press coverage about Stericycle (NASDAQ:SRCL) has trended somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Stericycle earned a coverage optimism score of 0.23 on Accern’s scale. Accern also assigned media headlines about the business services provider an impact score of 47.4754694295549 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

Shares of NASDAQ:SRCL opened at $61.32 on Friday. Stericycle has a 1 year low of $56.64 and a 1 year high of $76.73. The stock has a market cap of $5.34 billion, a P/E ratio of 14.13, a price-to-earnings-growth ratio of 1.45 and a beta of 0.42. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.87.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, August 2nd. The business services provider reported $1.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.13 by $0.04. Stericycle had a return on equity of 14.04% and a net margin of 5.03%. The company had revenue of $883.30 million for the quarter, compared to the consensus estimate of $896.62 million. During the same quarter in the previous year, the business earned $1.15 EPS. Stericycle’s revenue was down 3.7% compared to the same quarter last year. analysts expect that Stericycle will post 4.46 earnings per share for the current fiscal year.

Several research firms have recently commented on SRCL. Jefferies Financial Group set a $75.00 price objective on Stericycle and gave the stock a “buy” rating in a report on Thursday, August 2nd. BidaskClub upgraded Stericycle from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 31st. Zacks Investment Research downgraded Stericycle from a “buy” rating to a “hold” rating in a report on Monday, July 16th. BMO Capital Markets reiterated a “hold” rating and issued a $71.00 price objective on shares of Stericycle in a report on Thursday, July 12th. Finally, Barrington Research reiterated a “buy” rating on shares of Stericycle in a report on Friday, June 1st. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. Stericycle currently has a consensus rating of “Hold” and a consensus target price of $71.71.

In related news, CEO Charles A. Alutto sold 13,000 shares of the business’s stock in a transaction dated Tuesday, May 29th. The stock was sold at an average price of $62.68, for a total transaction of $814,840.00. Following the transaction, the chief executive officer now owns 17,026 shares in the company, valued at approximately $1,067,189.68. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Daniel Ginnetti sold 5,000 shares of the business’s stock in a transaction dated Wednesday, August 1st. The shares were sold at an average price of $70.00, for a total value of $350,000.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 183,541 shares of company stock worth $11,963,741. 3.50% of the stock is owned by company insiders.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

Recommended Story: What is a Tariff?

Insider Buying and Selling by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.